Rigel Announces Conference Call and Webcast to Report First Quarter 2023 Financial Results and Business Update

Rhea-AI Summary

Rigel Pharmaceuticals (Nasdaq: RIGL) will announce its first quarter 2023 financial results after market close on May 2, 2023. Following the results release, a live conference call will take place at 4:30 p.m. ET to discuss the outcomes and provide business updates. Interested participants can join the call at 877-407-3088 domestically or 201-389-0927 internationally, or access the webcast via the Rigel website. The archived recording will be available for 90 days post-call. Rigel is focused on developing therapies for hematologic disorders and cancer.

Positive

• Scheduled announcement of first quarter 2023 financial results may indicate ongoing operational activities.
• Live conference call allows investors to gain insights directly from management.

Negative

• None.

SOUTH SAN FRANCISCO, Calif., April 25, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2023 financial results after market close on Tuesday, May 2, 2023. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.

Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com

Contact for Investors & Media:

Investors:
Rigel Pharmaceuticals, Inc. 
650.624.1232
ir@rigel.com  

Media:
David Rosen 
Argot Partners 
212.600.1902
david.rosen@argotpartners.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-first-quarter-2023-financial-results-and-business-update-301806257.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

When will Rigel Pharmaceuticals report its first quarter 2023 financial results?

Rigel Pharmaceuticals will report its first quarter 2023 financial results on May 2, 2023.

What time is the Rigel Pharmaceuticals conference call on May 2, 2023?

The conference call will start at 4:30 p.m. Eastern Time on May 2, 2023.

How can I access the Rigel Pharmaceuticals financial results conference call?

The conference call can be accessed by dialing 877-407-3088 domestically or 201-389-0927 internationally, and it will also be available via webcast on the Rigel website.

Will the Rigel Pharmaceuticals conference call be available for replay?

Yes, the webcast will be archived and available for replay for 90 days after the call.